Similar articles for PMID: 16330567

Year	Number of Results
1998	1
2001	1
2002	1
2003	1
2004	2
2005	4
2006	3
2007	7
2008	5
2009	7
2010	5
2011	5
2012	7
2013	5
2014	7
2015	9
2016	8
2017	9
2018	5
2019	6
2020	4
2021	2
2022	1
2024	0

1

Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.

Wieder HA, Beer AJ, Lordick F, Ott K, Fischer M, Rummeny EJ, Ziegler S, Siewer JR, Schwaiger M, Weber WA. Wieder HA, et al. J Nucl Med. 2005 Dec;46(12):2029-34. J Nucl Med. 2005. PMID: 16330567 Free article.

2

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW. Lorenzen S, et al. BMC Cancer. 2011 Jun 24;11:266. doi: 10.1186/1471-2407-11-266. BMC Cancer. 2011. PMID: 21702914 Free PMC article.

3

Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.

Weber MA, Bender K, von Gall CC, Stange A, Grünberg K, Ott K, Haberkorn U, Kauczor HU, Zechmann C. Weber MA, et al. J Gastrointestin Liver Dis. 2013 Mar;22(1):45-52. J Gastrointestin Liver Dis. 2013. PMID: 23539390 Free article.

4

Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.

Wieder HA, Ott K, Lordick F, Becker K, Stahl A, Herrmann K, Fink U, Siewert JR, Schwaiger M, Weber WA. Wieder HA, et al. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1925-32. doi: 10.1007/s00259-007-0521-3. Epub 2007 Aug 7. Eur J Nucl Med Mol Imaging. 2007. PMID: 17680242

5

Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Ott K, Weber WA, Fink U, Helmberger H, Becker K, Stein HJ, Müller J, Schwaiger M, Siewert JR. Ott K, et al. World J Surg. 2003 Sep;27(9):1035-9. doi: 10.1007/s00268-003-7058-9. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917760

6

[¹⁸ F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction.

Harustiak T, Zemanova M, Fencl P, Hornofova L, Pazdro A, Snajdauf M, Salkova E, Lischke R, Stolz A. Harustiak T, et al. Br J Surg. 2018 Mar;105(4):419-428. doi: 10.1002/bjs.10712. Epub 2018 Feb 8. Br J Surg. 2018. PMID: 29417984 Clinical Trial.

7

Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma.

Sánchez-Izquierdo N, Perlaza P, Pagès M, Buxó E, Rios J, Rubello D, Colletti PM, Mayoral M, Casanueva S, Fernández-Esparrach G, Ginés A, Fuster D. Sánchez-Izquierdo N, et al. Clin Nucl Med. 2020 Jan;45(1):38-43. doi: 10.1097/RLU.0000000000002840. Clin Nucl Med. 2020. PMID: 31714278 Clinical Trial.

8

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

Ott K, Weber WA, Lordick F, Becker K, Busch R, Herrmann K, Wieder H, Fink U, Schwaiger M, Siewert JR. Ott K, et al. J Clin Oncol. 2006 Oct 10;24(29):4692-8. doi: 10.1200/JCO.2006.06.7801. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966684

9

¹⁸FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.

Lehmann K, Eshmuminov D, Bauerfeind P, Gubler C, Veit-Haibach P, Weber A, Abdul-Rahman H, Fischer M, Reiner C, Schneider PM. Lehmann K, et al. Eur J Surg Oncol. 2017 Jan;43(1):196-202. doi: 10.1016/j.ejso.2016.08.020. Epub 2016 Sep 7. Eur J Surg Oncol. 2017. PMID: 27692533 Free article.

10

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

zum Büschenfelde CM, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ. zum Büschenfelde CM, et al. J Nucl Med. 2011 Aug;52(8):1189-96. doi: 10.2967/jnumed.110.085803. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764790 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year